<p>Geode Capital Management LLC 在最近向證券交易委員會的披露中表示，在第二季度其在 Regencell Bioscience Holdings Limited (NASDAQ:RGC - 免費報告) 的持股增加了 5,637.5%。該公司在此期間購買了額外的 384,250 股後，持有該公司 391,066 股股票。Geode Capital Management LLC 在 Regencell Bioscience 的持股在最近的報告期末價值為 6,664,000 美元。</p>
<p>獲取 <strong>Regencell Bioscience</strong> 的提醒：</p>
<ul>
<li>按表現排名的最佳股票選擇 AI</li>
</ul>
<p>另外，Greenfield Savings Bank 在第二季度收購了 Regencell Bioscience 的新股份，價值 187,000 美元。對沖基金和其他機構投資者持有該公司 0.13% 的股票。</p>
<h2>華爾街分析師預測增長</h2>
<p>另外，Weiss Ratings 在週一的一份研究報告中重申了對 Regencell Bioscience 股票的 &#34;賣出 (e+)&#34; 評級。根據 MarketBeat 的數據，一位股票研究分析師對該股票給予了賣出評級，該公司的共識評級為 &#34;賣出&#34;。</p>
<p><strong>閲讀我們關於 Regencell Bioscience 的最新股票報告</strong></p>
<h2>Regencell Bioscience 股票上漲 1.5%</h2>
<p>RGC 股票在週五開盤價為 16.24 美元。該公司的 50 日移動平均線為 15.00 美元。Regencell Bioscience Holdings Limited 的一年最低價為 0.09 美元，一年最高價為 83.60 美元。</p>
<h2>Regencell Bioscience 簡介</h2>
<p>(免費報告)</p>
<p>Regencell Bioscience Holdings Limited 運營一家傳統中醫 (TCM) 生物科技公司。它專注於中醫的研究、開發和商業化，旨在治療神經認知障礙和退化，主要是注意力缺陷多動症和自閉症譜系障礙。</p>
<h2>精選文章</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Regencell Bioscience</li>
<li>今日最大股票虧損者 - 最大百分比下跌者</li>
<li>Rocket Lab 的大反彈？分析師建議此跌幅是個機會</li>
<li>消費者價格指數測量什麼？</li>
<li>Meta 的 AI 時刻？新 SAM 3 模型讓華爾街轉向看漲</li>
<li>上海證券交易所綜合指數是什麼？</li>
<li>Snowflake 股票：聰明投資者現在正在購買的跌幅</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UkdD?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UkdD"/></p>
<p><em>此即時新聞提醒由敍述科學技術和來自 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Regencell Bioscience 嗎？</h2>
<p>在考慮 Regencell Bioscience 之前，你會想聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前... 而 Regencell Bioscience 並不在名單上。</p>
<p>雖然 Regencell Bioscience 目前在分析師中被評為賣出，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

腦再生科技

<p>Geode Capital Management LLC 在第二季度將其在腦再生科技的持股增加了 5,637.5%，目前市值為 666 萬美元。儘管如此，分析師對該股票維持 “賣出” 評級。腦再生科技專注於針對神經認知障礙的傳統中醫。該股票開盤價為 16.24 美元，52 周價格區間為 0.09 至 83.60 美元。機構投資者持有該股票的 0.13%</p>

<p>Geode Capital Management LLC increased its position in shares of Regencell Bioscience Holdings Limited (NASDAQ:RGC - Free Report) by 5,637.5% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 391,066 shares of the company's stock after purchasing an additional 384,250 shares during the period. Geode Capital Management LLC's holdings in Regencell Bioscience were worth $6,664,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>Geode Capital Management LLC 在最近向證券交易委員會的披露中表示，在第二季度其在 Regencell Bioscience Holdings Limited (NASDAQ:RGC - 免費報告) 的持股增加了 5,637.5%。該公司在此期間購買了額外的 384,250 股後，持有該公司 391,066 股股票。Geode Capital Management LLC 在 Regencell Bioscience 的持股在最近的報告期末價值為 6,664,000 美元。</p>
</div><p>Get <strong>Regencell Bioscience</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Regencell Bioscience</strong> 的提醒：</p>
</div><ul>
<li>The Best AI for Picking Stocks, Ranked by Performance</li>
</ul>
<div class="lb-trans"><ul>
<li>按表現排名的最佳股票選擇 AI</li>
</ul>
</div><p>Separately, Greenfield Savings Bank acquired a new stake in Regencell Bioscience during the second quarter worth $187,000. Hedge funds and other institutional investors own 0.13% of the company's stock.</p>
<div class="lb-trans"><p>另外，Greenfield Savings Bank 在第二季度收購了 Regencell Bioscience 的新股份，價值 187,000 美元。對沖基金和其他機構投資者持有該公司 0.13% 的股票。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>華爾街分析師預測增長</h2>
</div><p>Separately, Weiss Ratings restated a &#34;sell (e+)&#34; rating on shares of Regencell Bioscience in a research note on Monday. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the company has a consensus rating of &#34;Sell&#34;.</p>
<div class="lb-trans"><p>另外，Weiss Ratings 在週一的一份研究報告中重申了對 Regencell Bioscience 股票的 &#34;賣出 (e+)&#34; 評級。根據 MarketBeat 的數據，一位股票研究分析師對該股票給予了賣出評級，該公司的共識評級為 &#34;賣出&#34;。</p>
</div><p><strong>Read Our Latest Stock Report on Regencell Bioscience</strong></p>
<div class="lb-trans"><p><strong>閲讀我們關於 Regencell Bioscience 的最新股票報告</strong></p>
</div><h2>Regencell Bioscience Trading Up 1.5%</h2>
<div class="lb-trans"><h2>Regencell Bioscience 股票上漲 1.5%</h2>
</div><p>Shares of RGC stock opened at $16.24 on Friday. The company has a fifty day moving average of $15.00. Regencell Bioscience Holdings Limited has a one year low of $0.09 and a one year high of $83.60.</p>
<div class="lb-trans"><p>RGC 股票在週五開盤價為 16.24 美元。該公司的 50 日移動平均線為 15.00 美元。Regencell Bioscience Holdings Limited 的一年最低價為 0.09 美元，一年最高價為 83.60 美元。</p>
</div><h2>Regencell Bioscience Profile</h2>
<div class="lb-trans"><h2>Regencell Bioscience 簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免費報告)</p>
</div><p>Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.</p>
<div class="lb-trans"><p>Regencell Bioscience Holdings Limited 運營一家傳統中醫 (TCM) 生物科技公司。它專注於中醫的研究、開發和商業化，旨在治療神經認知障礙和退化，主要是注意力缺陷多動症和自閉症譜系障礙。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精選文章</h2>
</div><ul>
<li>Five stocks we like better than Regencell Bioscience</li>
<li>Biggest Stock Losers - Today’s Biggest Percentage Decliners</li>
<li>Rocket Lab’s Big Rebound? Analysts Suggest the Dip's a Gift</li>
<li>What does consumer price index measure?</li>
<li>Meta’s AI Moment? New SAM 3 Model Has Wall Street Turning Bullish</li>
<li>What is the Shanghai Stock Exchange Composite Index?</li>
<li>Snowflake Stock: The Dip That Smart Investors Are Buying Right Now</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Regencell Bioscience</li>
<li>今日最大股票虧損者 - 最大百分比下跌者</li>
<li>Rocket Lab 的大反彈？分析師建議此跌幅是個機會</li>
<li>消費者價格指數測量什麼？</li>
<li>Meta 的 AI 時刻？新 SAM 3 模型讓華爾街轉向看漲</li>
<li>上海證券交易所綜合指數是什麼？</li>
<li>Snowflake 股票：聰明投資者現在正在購買的跌幅</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UkdD" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=RGC"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和來自 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Regencell Bioscience Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Regencell Bioscience 嗎？</h2>
</div><p>Before you consider Regencell Bioscience, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Regencell Bioscience 之前，你會想聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Regencell Bioscience wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前... 而 Regencell Bioscience 並不在名單上。</p>
</div><p>While Regencell Bioscience currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Regencell Bioscience 目前在分析師中被評為賣出，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Geode Capital Management LLC 持有腦再生科技控股有限公司價值 666 萬美元的股份